Skip to main content
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 2/2023

19.12.2022 | Original Article

Survival Outcomes and Factors Affecting Survival in Resectable Locally Advanced Oral Squamous Cell Carcinoma

verfasst von: Rathindra Nath Bera, Richik Tripathi

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Management of locally advanced OSCC include primary surgery followed by adjuvant radiotherapy or chemo radiation, concurrent chemo radiation, induction chemotherapy followed by surgery or non surgical methods. In resectable disease the role of induction chemotherapy is questionable and surgery remains the first choice. In this study we aimed at evaluating the survival and factors effecting survival in locally advanced oral cancer. retrospective review of patient records was made. Kaplan Meir method was used to evaluate OS and DFS rate and log rank test was used to compare the survival amongst groups. Cox regression analysis (univariate and multivariate) was used to evaluate the hazard ratio to find out the possible factors influencing risk of death and disease. The 3 year OS of the entire cohort was 56.80% and 3 year DFS was 52.4%. ECS, surgical margin, PNI, LVI and LN size were independent risk factors for poor overall and disease free survival. We identified ECS, positive margin, LVI, PNI and LN size as independent risk factors effecting survival. These factors justify the use of adjuvant radiotherapy or chemo radiation according to the already available guidelines.
Literatur
1.
Zurück zum Zitat Huang SH, O’Sullivan B (2017) Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Opt Oncol 18(7):40CrossRef Huang SH, O’Sullivan B (2017) Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Opt Oncol 18(7):40CrossRef
2.
Zurück zum Zitat Dhar H, Vaish R, D’Cruz AK (2020) Management of locally advanced oral cancers. Oral Oncol 105:104662CrossRefPubMed Dhar H, Vaish R, D’Cruz AK (2020) Management of locally advanced oral cancers. Oral Oncol 105:104662CrossRefPubMed
3.
4.
Zurück zum Zitat Neville BW, Day TA (2002) Oral cancer and precancerous lesions. CA Cancer J Clin 52:195–215CrossRefPubMed Neville BW, Day TA (2002) Oral cancer and precancerous lesions. CA Cancer J Clin 52:195–215CrossRefPubMed
5.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108CrossRefPubMed Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108CrossRefPubMed
6.
Zurück zum Zitat Patil VM, Prabhash K, Noronha V et al (2014) Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers. Oral Oncol 50(10):1000–1004CrossRefPubMed Patil VM, Prabhash K, Noronha V et al (2014) Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers. Oral Oncol 50(10):1000–1004CrossRefPubMed
7.
Zurück zum Zitat Yousem DM, Gad K, Tufano RP (2006) Resectability issues with head and neck cancer. AJNR Am J Neuroradiol 27(10):2024–2036PubMedPubMedCentral Yousem DM, Gad K, Tufano RP (2006) Resectability issues with head and neck cancer. AJNR Am J Neuroradiol 27(10):2024–2036PubMedPubMedCentral
8.
Zurück zum Zitat Yousem DM, Hatabu H, Hurst RW et al (1995) Carotid artery invasion by head and neck masses: prediction with MR imaging. Radiology 195(3):715–720CrossRefPubMed Yousem DM, Hatabu H, Hurst RW et al (1995) Carotid artery invasion by head and neck masses: prediction with MR imaging. Radiology 195(3):715–720CrossRefPubMed
9.
Zurück zum Zitat Santos FMD, Viani GA, Pavoni JF (2021) Evaluation of survival of patients with locally advanced head and neck cancer treated in a single center. Braz J Otorhinolaryngol 87(1):3–10CrossRefPubMed Santos FMD, Viani GA, Pavoni JF (2021) Evaluation of survival of patients with locally advanced head and neck cancer treated in a single center. Braz J Otorhinolaryngol 87(1):3–10CrossRefPubMed
10.
Zurück zum Zitat Cmelak AJ, Arneson K, Chau NG, Gilbert RW, Haddad RI (2013) Locally advanced head and neck cancer. Am Soc Clin Oncol Educ Book 237–44 Cmelak AJ, Arneson K, Chau NG, Gilbert RW, Haddad RI (2013) Locally advanced head and neck cancer. Am Soc Clin Oncol Educ Book 237–44
11.
Zurück zum Zitat Gau M, Karabajakian A, Reverdy T, Neidhardt EM, Fayette J (2019) Induction chemotherapy in head and neck cancers: results and controversies. Oral Oncol 95:164–169CrossRefPubMed Gau M, Karabajakian A, Reverdy T, Neidhardt EM, Fayette J (2019) Induction chemotherapy in head and neck cancers: results and controversies. Oral Oncol 95:164–169CrossRefPubMed
12.
Zurück zum Zitat Haddad R, O’Neill A, Rabinowits G et al (2013) Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol 14(3):257–264CrossRefPubMed Haddad R, O’Neill A, Rabinowits G et al (2013) Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol 14(3):257–264CrossRefPubMed
13.
Zurück zum Zitat Lacas B, Carmel A, Landais C et al (2021) MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group. Radiother Oncol 156:281–293CrossRefPubMedPubMedCentral Lacas B, Carmel A, Landais C et al (2021) MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group. Radiother Oncol 156:281–293CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat National comprehensive cancer network clinical practice guidelines in oncology, head and neck cancers, version 1.2021. 9 November 2020. Accessed 11 March 2022. http://www.nccn.org/ National comprehensive cancer network clinical practice guidelines in oncology, head and neck cancers, version 1.2021. 9 November 2020. Accessed 11 March 2022. http://​www.​nccn.​org/​
15.
Zurück zum Zitat Licitra L, Grandi C, Guzzo M et al (2003) Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol 21(2):327–333CrossRefPubMed Licitra L, Grandi C, Guzzo M et al (2003) Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol 21(2):327–333CrossRefPubMed
16.
Zurück zum Zitat Zhong LP, Zhang CP, Ren GX et al (2013) Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol 31(6):744–751CrossRefPubMed Zhong LP, Zhang CP, Ren GX et al (2013) Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol 31(6):744–751CrossRefPubMed
17.
Zurück zum Zitat Lau A, Li KY, Yang WF, Su YX (2016) Induction chemotherapy for squamous cell carcinomas of the oral cavity: a cumulative meta-analysis. Oral Oncol 61:104–114CrossRefPubMed Lau A, Li KY, Yang WF, Su YX (2016) Induction chemotherapy for squamous cell carcinomas of the oral cavity: a cumulative meta-analysis. Oral Oncol 61:104–114CrossRefPubMed
18.
Zurück zum Zitat Rudresha AH, Chaudhuri T, Lakshmaiah KC et al (2017) Induction chemotherapy in technically unresectable locally advanced T4a oral cavity squamous cell cancers: experience from a regional cancer center of South India. Indian J Med Paediatr Oncol 38(4):490–494CrossRefPubMedPubMedCentral Rudresha AH, Chaudhuri T, Lakshmaiah KC et al (2017) Induction chemotherapy in technically unresectable locally advanced T4a oral cavity squamous cell cancers: experience from a regional cancer center of South India. Indian J Med Paediatr Oncol 38(4):490–494CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Liao CT, Ng SH, Chang JT et al (2007) T4b oral cavity cancer below the mandibular notch is resectable with a favorable outcome. Oral Oncol 43:570–579CrossRefPubMed Liao CT, Ng SH, Chang JT et al (2007) T4b oral cavity cancer below the mandibular notch is resectable with a favorable outcome. Oral Oncol 43:570–579CrossRefPubMed
20.
Zurück zum Zitat Baddour HM, Ochsner MC, Patel MR et al (2021) Surgical resection is justifiable for oral T4b squamous cell cancers with masticator space invasion. Laryngoscope 131(2):E466–E472CrossRefPubMed Baddour HM, Ochsner MC, Patel MR et al (2021) Surgical resection is justifiable for oral T4b squamous cell cancers with masticator space invasion. Laryngoscope 131(2):E466–E472CrossRefPubMed
21.
Zurück zum Zitat Gangopadhyay A, Bhatt S, Nandy K, Rai S, Rathod P, Puj KS (2021) Survival impact of surgical resection in locally advanced t4b oral squamous cell carcinoma. Laryngoscope 131(7):E2266–E2274CrossRefPubMed Gangopadhyay A, Bhatt S, Nandy K, Rai S, Rathod P, Puj KS (2021) Survival impact of surgical resection in locally advanced t4b oral squamous cell carcinoma. Laryngoscope 131(7):E2266–E2274CrossRefPubMed
22.
Zurück zum Zitat Vandenbroucke JP, von Elm E, Altman DG et al (2007) STROBE initiative. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med 4(10):e297CrossRefPubMedPubMedCentral Vandenbroucke JP, von Elm E, Altman DG et al (2007) STROBE initiative. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med 4(10):e297CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Amin MB, ES, Greene FL et al (eds) (2017) AJCC cancer staging manual, 8th ed. Springer International Publishing: American Joint Commission on Cancer, New York Amin MB, ES, Greene FL et al (eds) (2017) AJCC cancer staging manual, 8th ed. Springer International Publishing: American Joint Commission on Cancer, New York
24.
Zurück zum Zitat Huang SH, O’Sullivan B (2017) Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Opt Oncol 18(40):1–13 Huang SH, O’Sullivan B (2017) Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Opt Oncol 18(40):1–13
25.
Zurück zum Zitat Helliwell T, Woolgar J (2013) Dataset for histopathology reporting of mucosal malignancies of the oral cavity. The Royal College of Pathologists, London Helliwell T, Woolgar J (2013) Dataset for histopathology reporting of mucosal malignancies of the oral cavity. The Royal College of Pathologists, London
26.
Zurück zum Zitat Brandwein-Gensler M, Teixeira MS, Lewis CM et al (2005) Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 29(2):167–178CrossRefPubMed Brandwein-Gensler M, Teixeira MS, Lewis CM et al (2005) Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 29(2):167–178CrossRefPubMed
27.
Zurück zum Zitat Parekh D, Kukreja P, Mallick I et al (2020) Worst pattern of invasion—type 4 (WPOI-4) and Lymphocyte host response should be mandatory reporting criteria for oral cavity squamous cell carcinoma: a re-look at the American Joint Committee of Cancer (AJCC) minimum dataset. Indian J Pathol Microbiol 63(4):527–533CrossRefPubMed Parekh D, Kukreja P, Mallick I et al (2020) Worst pattern of invasion—type 4 (WPOI-4) and Lymphocyte host response should be mandatory reporting criteria for oral cavity squamous cell carcinoma: a re-look at the American Joint Committee of Cancer (AJCC) minimum dataset. Indian J Pathol Microbiol 63(4):527–533CrossRefPubMed
28.
Zurück zum Zitat Alzahrani R, Obaid A, Al-Hakami H et al (2020) Locally advanced oral cavity cancers: what is the optimal care? Cancer Control 27(1):1073274820920727CrossRefPubMedPubMedCentral Alzahrani R, Obaid A, Al-Hakami H et al (2020) Locally advanced oral cavity cancers: what is the optimal care? Cancer Control 27(1):1073274820920727CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Thakar A, Thakur R, Kakkar A et al (2021) Oral cancer in the Indian subcontinent-survival outcomes and risk factors with primary surgery. Laryngoscope 131(10):2254–2261CrossRefPubMed Thakar A, Thakur R, Kakkar A et al (2021) Oral cancer in the Indian subcontinent-survival outcomes and risk factors with primary surgery. Laryngoscope 131(10):2254–2261CrossRefPubMed
30.
Zurück zum Zitat Kumar A, Singh R, Santhosh M et al (2021) Role of structures in the masticator space in selecting patients with resectable T4b oral cancer: findings from a survival analysis. Int J Oral Maxillofac Surg 50(5):579–584CrossRefPubMed Kumar A, Singh R, Santhosh M et al (2021) Role of structures in the masticator space in selecting patients with resectable T4b oral cancer: findings from a survival analysis. Int J Oral Maxillofac Surg 50(5):579–584CrossRefPubMed
31.
Zurück zum Zitat Chang WC, Chang CF, Li YH et al (2019) A histopathological evaluation and potential prognostic implications of oral squamous cell carcinoma with adverse features. Oral Oncol 95:65–73CrossRefPubMed Chang WC, Chang CF, Li YH et al (2019) A histopathological evaluation and potential prognostic implications of oral squamous cell carcinoma with adverse features. Oral Oncol 95:65–73CrossRefPubMed
32.
Zurück zum Zitat Vincent N, Dassonville O, Chamorey E et al (2012) Clinical and histological prognostic factors in locally advanced oral cavity cancers treated with primary surgery. Eur Ann Otorhinolaryngol Head Neck Dis 129(6):291–296CrossRefPubMed Vincent N, Dassonville O, Chamorey E et al (2012) Clinical and histological prognostic factors in locally advanced oral cavity cancers treated with primary surgery. Eur Ann Otorhinolaryngol Head Neck Dis 129(6):291–296CrossRefPubMed
33.
Zurück zum Zitat Lee LY, Lin CY, Cheng NM et al (2021) Poor tumor differentiation is an independent adverse prognostic variable in patients with locally advanced oral cavity cancer—comparison with pathological risk factors according to the NCCN guidelines. Cancer Med 10(19):6627–6641CrossRefPubMedPubMedCentral Lee LY, Lin CY, Cheng NM et al (2021) Poor tumor differentiation is an independent adverse prognostic variable in patients with locally advanced oral cavity cancer—comparison with pathological risk factors according to the NCCN guidelines. Cancer Med 10(19):6627–6641CrossRefPubMedPubMedCentral
Metadaten
Titel
Survival Outcomes and Factors Affecting Survival in Resectable Locally Advanced Oral Squamous Cell Carcinoma
verfasst von
Rathindra Nath Bera
Richik Tripathi
Publikationsdatum
19.12.2022
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 2/2023
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-022-03404-7

Weitere Artikel der Ausgabe 2/2023

Indian Journal of Otolaryngology and Head & Neck Surgery 2/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.